Timothy R Franson Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Timothy R Franson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Timothy R Franson. Timothy R Franson is a Director in Paratek Pharmaceuticals, Inc. ($PRTK) and a Director in Myrexis, Inc. ($MYRX) and a in Cidara Therapeutics, Inc. ($CDTX) and a Director in Cidara Therapeutics, Inc. ($CDTX).
Address: C/O MYRIAD PHARMACEUTICALS, INC. 320 WAKARA WAY SALT LAKE CITY 84108 UT
Companies in which Timothy R Franson is an Insider
Cidara Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Timothy R Franson:
Holdings: 4,000 shares
Current Value: $38,400
Latest Transaction: Jun 25 2020
$CDTX Market Capitalization: $167.56M
$CDTX Previous Close: $9.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Myrexis, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Timothy R Franson: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 14 2009
$MYRX Market Capitalization: $1.38M
$MYRX Previous Close: $0.04
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Paratek Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Timothy R Franson: Director
Holdings: 39,000 shares
Current Value: $594,750
Latest Transaction: Feb 22 2021
$PRTK Market Capitalization: $346.19M
$PRTK Previous Close: $15.25
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Timothy R Franson
Sentiment: All, CDTX, MYRX, PRTK
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 22 2021 | PRTK | Paratek Pharmaceut ... | Franson Timothy R | Director | Option Exercise | A | 7.61 | 7,000 | 53,270 | 7,000 | |
| Feb 22 2021 | PRTK | Paratek Pharmaceut ... | Franson Timothy R | Director | Grant | A | 0.00 | 9,000 | 0 | 39,000 | 30 K to 39 K (+30.00 %) |
| Jun 25 2020 | CDTX | Cidara Therapeutic ... | Franson Timothy R | Option Exercise | A | 3.97 | 17,500 | 69,475 | 17,500 | ||
| Feb 21 2020 | PRTK | Paratek Pharmaceut ... | Franson Timothy R | Director | Option Exercise | A | 3.51 | 7,000 | 24,570 | 7,000 | |
| Feb 21 2020 | PRTK | Paratek Pharmaceut ... | Franson Timothy R | Director | Grant | A | 0.00 | 9,000 | 0 | 30,000 | 21 K to 30 K (+42.86 %) |
| Jun 27 2019 | CDTX | Cidara Therapeutic ... | Franson Timothy R | Director | Option Exercise | A | 1.60 | 11,000 | 17,600 | 11,000 | |
| Feb 28 2019 | PRTK | Paratek Pharmaceut ... | Franson Timothy R | Director | Option Exercise | A | 7.23 | 5,000 | 36,150 | 5,000 |